Mediclinic International plc
(Incorporated in England and Wales)
Company Number 8338604
LSE Share Code: MDC
JSE Share Code: MEI
NSX Share Code: MEP
ISIN: GB00B8HX8Z88
LEI: 2138002S5BSBIZTD5I60
7 April 2017
Notification of Major Interest in Mediclinic International plc shares
1. Identity of the issuer or the underlying issuer
of existing shares to which voting rights are
attached: |
Mediclinic International plc |
2 Reason for the notification (please tick the appropriate box or boxes): |
An acquisition or disposal of voting rights |
x |
An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached |
|
An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments |
|
An event changing the breakdown of voting rights |
|
Other (please specify): |
|
|
3. Full name of person(s) subject to the
notification obligation: |
Coronation Asset Management (Pty) Ltd |
4. Full name of shareholder(s)
(if different from 3.): |
N/A |
5. Date of the transaction and date on
which the threshold is crossed or
reached: |
07 April 2017 |
6. Date on which issuer notified: |
07 April 2017 |
7. Threshold(s) that is/are crossed or
reached: |
5% |
|
|
|
|
|
8. Notified details: |
A: Voting rights attached to shares |
Class/type of
shares
if possible using
the ISIN CODE
|
Situation previous
to the triggering
transaction |
Resulting situation after the triggering transaction |
Number
of
Shares |
Number
of
Voting
Rights |
Number
of shares |
Number of voting
rights |
% of voting rights |
Direct |
Direct |
Indirect |
Direct |
Indirect |
GB00B8HX8Z88 |
36 084 874 |
36 084 874 |
36 852 189 |
36 852 189 |
|
5.00% |
|
|
|
B: Qualifying Financial Instruments |
Resulting situation after the triggering transaction |
Type of financial
instrument |
Expiration
date |
Exercise/
Conversion Period |
Number of voting
rights that may be
acquired if the
instrument is
exercised/ converted. |
% of voting
rights |
|
|
|
|
|
|
C: Financial Instruments with similar economic effect to Qualifying Financial Instruments |
Resulting situation after the triggering transaction |
Type of financial
instrument |
Exercise price |
Expiration date |
Exercise/
Conversion period |
Number of voting rights instrument refers to |
% of voting rights |
|
|
|
|
|
Nominal |
Delta |
|
|
|
Total (A+B+C) |
Number of voting rights |
Percentage of voting rights |
36 852 189 |
5.00% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
9. Chain of controlled undertakings through which the voting rights and/or the
financial instruments are effectively held, if applicable: |
|
|
Proxy Voting: |
10. Name of the proxy holder: |
Coronation Asset Management (Pty) Ltd |
11. Number of voting rights proxy holder will cease to hold: |
|
12. Date on which proxy holder will cease to hold voting rights: |
|
|
13. Additional information:
|
|
14. Contact name: |
Jamie Rowland |
15. Contact telephone number: |
+27 21 680 2000 |
|
|
|
Mediclinic's primary listing is on the Main Market of the LSE, with secondary listings on the JSE in South
Africa and on the NSX in Namibia.
Registered address: 1st Floor, 40 Dukes Place, London, EC3A 7NH, United Kingdom
Website: www.mediclinic.com
Corporate broker: Morgan Stanley & Co International plc
JSE sponsor: Rand Merchant Bank (A division of FirstRand Bank Limited)
NSX sponsor: Simonis Storm Securities (Pty) Ltd
For further information please contact:
Mediclinic International plc
James Arnold, Head of Investor Relations
ir@mediclinic.com
Capita Company Secretarial Services Limited
Victoria Dalby
+44 (0)207 954 9600